Parabilis Medicines, Inc. Unrealized Gain (Loss) on Price Risk Fair Value Hedging Instruments
Parabilis Medicines, Inc. (PBLS) reported Unrealized Gain (Loss) on Price Risk Fair Value Hedging Instruments of $33.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:UnrealizedGainLossOnPriceRiskFairValueHedgingInstruments · last filed 2026-08-13
- 2026-06-30: Unrealized Gain (Loss) on Price Risk Fair Value Hedging Instruments 6 month $33.60M.
| Period end | Unrealized Gain (Loss) on Price Risk Fair Value Hedging Instruments 6 month |
|---|---|
| 2026-06-30 | $33.60M 10-Q · filed 2026-08-13 |